Cubist Systematic Strategies’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $896K | Sell |
11,525
-67,978
| -86% | -$5.31M | ﹤0.01% | 1989 |
|
|
2025
Q2 | $6.22M | Sell |
79,503
-193,770
| -71% | -$14.5M | 0.03% | 885 |
|
|
2025
Q1 | $19.8M | Buy |
+273,273
| New | +$19.6M | 0.12% | 200 |
|
|
2024
Q4 | – | Sell |
-303,718
| Closed | -$21.3M | – | 3139 |
|
|
2024
Q3 | $20M | Buy |
+303,718
| New | +$22.1M | 0.12% | 186 |
|
|
2023
Q4 | – | Sell |
-289,229
| Closed | -$20.1M | – | 3726 |
|
|
2023
Q3 | $20M | Buy |
+289,229
| New | +$23.2M | 0.15% | 122 |
|
|
2023
Q2 | – | Sell |
-111,818
| Closed | -$9.72M | – | 3744 |
|
|
2023
Q1 | $9.25M | Sell |
111,818
-237,776
| -68% | -$18.7M | 0.06% | 508 |
|
|
2022
Q4 | $26.1M | Buy |
349,594
+134,830
| +63% | +$10.4M | 0.15% | 77 |
|
|
2022
Q3 | $17.7M | Buy |
214,764
+192,902
| +882% | +$18.6M | 0.1% | 192 |
|
|
2022
Q2 | $2.08M | Sell |
21,862
-3,587
| -14% | -$371K | 0.01% | 1825 |
|
|
2022
Q1 | $3M | Buy |
25,449
+10,768
| +73% | +$1.21M | 0.03% | 1151 |
|
|
2021
Q4 | $1.9M | Sell |
14,681
-32,584
| -69% | -$3.8M | 0.02% | 1413 |
|
|
2021
Q3 | $5.35M | Buy |
47,265
+26,662
| +129% | +$3.04M | 0.07% | 432 |
|
|
2021
Q2 | $2.13M | Sell |
20,603
-41,812
| -67% | -$3.94M | 0.02% | 1041 |
|
|
2021
Q1 | $5.22M | Buy |
62,415
+41,397
| +197% | +$3.5M | 0.07% | 435 |
|
|
2020
Q4 | $1.92M | Sell |
21,018
-187,690
| -90% | -$15.6M | 0.03% | 979 |
|
|
2020
Q3 | $16.7M | Sell |
208,708
-44,810
| -18% | -$3.5M | 0.25% | 43 |
|
|
2020
Q2 | $17.5M | Buy |
253,518
+17,514
| +7% | +$1.24M | 0.3% | 35 |
|
|
2020
Q1 | $14.8M | Sell |
236,004
-1,335
| -0.6% | -$96.3K | 0.4% | 27 |
|
|
2019
Q4 | $18.5M | Buy |
237,339
+235,287
| +11,466% | +$18.4M | 0.34% | 21 |
|
|
2019
Q3 | $150K | Sell |
2,052
-198,414
| -99% | -$13.9M | ﹤0.01% | 1857 |
|
|
2019
Q2 | $12.3M | Buy |
200,466
+198,708
| +11,303% | +$12M | 0.23% | 79 |
|
|
2019
Q1 | $112K | Sell |
1,758
-12,006
| -87% | -$685K | ﹤0.01% | 1971 |
|
|
2018
Q4 | $703K | Buy |
13,764
+9,864
| +253% | +$499K | 0.03% | 744 |
|
|
2018
Q3 | $226K | Sell |
3,900
-1,899
| -33% | -$92.9K | 0.01% | 1351 |
|
|
2018
Q2 | $281K | Sell |
5,799
-2,331
| -29% | -$109K | 0.01% | 1133 |
|
|
2018
Q1 | $378K | Sell |
8,130
-18,798
| -70% | -$816K | 0.02% | 992 |
|
|
2017
Q4 | $1.01M | Sell |
26,928
-155,478
| -85% | -$5.71M | 0.05% | 471 |
|
|
2017
Q3 | $6.65M | Buy |
182,406
+153,777
| +537% | +$5.86M | 0.37% | 20 |
|
|
2017
Q2 | $1.13M | Sell |
28,629
-9,351
| -25% | -$341K | 0.07% | 376 |
|
|
2017
Q1 | $1.19M | Sell |
37,980
-4,809
| -11% | -$151K | 0.08% | 281 |
|
|
2016
Q4 | $1.34M | Sell |
42,789
-4,947
| -10% | -$160K | 0.11% | 270 |
|
|
2016
Q3 | $1.92M | Sell |
47,736
-146,520
| -75% | -$5.52M | 0.12% | 212 |
|
|
2016
Q2 | $6.46M | Buy |
194,256
+87,912
| +83% | +$3.01M | 0.38% | 25 |
|
|
2016
Q1 | $3.13M | Sell |
106,344
-385,314
| -78% | -$10.6M | 0.18% | 115 |
|
|
2015
Q4 | $12.9M | Buy |
491,658
+473,844
| +2,660% | +$12.3M | 0.76% | 5 |
|
|
2015
Q3 | $422K | Sell |
17,814
-6,234
| -26% | -$150K | 0.02% | 1057 |
|
|
2015
Q2 | $571K | Sell |
24,048
-243,558
| -91% | -$5.5M | 0.03% | 880 |
|
|
2015
Q1 | $6.35M | Buy |
267,606
+80,826
| +43% | +$1.81M | 0.31% | 41 |
|
|
2014
Q4 | $3.96M | Buy |
186,780
+152,892
| +451% | +$3.07M | 0.21% | 77 |
|
|
2014
Q3 | $577K | Buy |
33,888
+13,986
| +70% | +$221K | 0.04% | 744 |
|
|
2014
Q2 | $285K | Buy |
+19,902
| New | +$270K | 0.02% | 990 |
|
Other funds holding EW
Cubist Systematic Strategies's EW Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its Edwards Lifesciences (EW) stake by 86% in Q3 2025, selling an estimated $5.31M and leaving 11,525 shares worth $896K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.
Cubist Systematic Strategies first reported a position in EW in Q2 2014 and has held it in 41 quarters since. The position peaked at $26.1M in Q4 2022. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.
- Cubist Systematic Strategies held 11,525 shares of Edwards Lifesciences worth $896K as of Q3 2025.
- Cubist Systematic Strategies sold 67,978 Edwards Lifesciences shares in Q3 2025, an estimated $5.31M.
- Edwards Lifesciences made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1989 holding.
- Cubist Systematic Strategies first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 41 quarters since.
- Cubist Systematic Strategies's Edwards Lifesciences position peaked at $26.1M in Q4 2022.
- 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.